Elmwood Wealth Management, Inc. Novo Nordisk A S Transaction History

Elmwood Wealth Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$93.1 - $112.54 $77,459 - $93,633	-832 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$95.88 - $117.08 $70,184 - $85,702	732 Added 732.0%	832 $93,000
Q2 2021 Aug 13, 2021	BUY	$67.66 - $84.76 $6,766 - $8,476	100 New	100 $8,000
Q1 2019 May 22, 2019	SELL	$46.36 - $52.63 $23,180 - $26,315	-500 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$41.54 - $47.25 $20,770 - $23,625	500 New	500 $23,000

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $198B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Elmwood Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Elmwood Wealth Management, Inc. with notifications on news.